Back to news archive
News 2020-10-14

Gradientech closes $9 million in oversubscribed investment round

Gradientech announces closure of an oversubscribed financing round totalling $9 million (SEK 80 million). The round was executed by a combination of existing shareholders and several new investors appointed by Swedish financial advisor Redeye. Bird & Bird Lawyers acted as legal advisors. The round was oversubscribed with almost 200%.

Link to press-release

Gradientech is an ISO13485 certified company since 2017


Gradientech AB
Uppsala Science Park
SE-751 83 Uppsala

About Gradientech

Gradientech develops, manufactures and sells innovative microfluidic products for high-quality analysis of the behavior of cells and organisms in response to gradients of biomolecules. Our aim is to pioneer life science and healthcare.

Copyright © 2023 Gradientech. All rights reserved. Gradientech, QuickMIC and CellDirector are registered trademarks or trademarks of Gradientech AB.

Next-generation antimicrobial susceptibility testing

Take a look at our E-book